生物模拟响应纳米转换器与免疫检查点阻塞加上抗血管生成用于高级肝细胞癌治疗

Yuting Zhang1,2, Aoxue Zhong2, Juan Min3

  • 1Innovation Center for Cancer Research, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, P. R. China.

PubMed
概括

一种新型纳米药物将血管生成抑制剂的向输送与免疫检查点阻塞相结合,通过减少瘤负担和转移而减少瘤负担和转移,显著改善晚期肝癌 (HCC) 模型的结果.